Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Hydroxy derivatives of S-2-(3-aminopropylamine)ethyl dihydrogen phosphorothioate and related compounds as antiradiation agents

Journal Article · · J. Med. Chem.; (United States)
DOI:https://doi.org/10.1021/jm00242a009· OSTI ID:7147884
The high antiradiation activity and low toxicity of sodium 3-amino-2-hydroxypropyl hydrogen phosphorothioate (1) suggested the introduction of hydroxyl groups into other types of radioprotective phosphorothioates. A number of such compounds were synthesized, including S-3-(3-aminopropylamino)-2-hydroxypropyl dihydrogen phosphorothioate (11, n = 3), S-2-(3-amino-2-hydroxypropylamino)ethyl dihydrogen phosphorothioate (20) and its propyl homolog 26, N,N'-(2-hydroxytrimethylene)bis(S-2-aminoethyl dihydrogen phosphorothioate) (40), S-2-(3-(2-hydroxyethylamino)propylamino)ethyl dihydrogen phosphorothioate (44), and sodium S-2-amino-2-(hydroxymethyl)-3-hydroxypropyl hydrogen phosphorothioate (49). Compounds 11 (n = 3), 20, 26, and 49 were highly protective when administered intraperitoneally but were generally ineffective when given perorally, as were the other hydroxylated phosphorothioates prepared. The introduction of hydroxyl groups significantly enhanced the radioprotective properties of nonhydroxylated parent compounds, however, only in the case of intraperitoneally administered 1.
Research Organization:
Kettering-Meyer Lab., Birmingham, AL
OSTI ID:
7147884
Journal Information:
J. Med. Chem.; (United States), Journal Name: J. Med. Chem.; (United States) Vol. 18:8; ISSN JMCMA
Country of Publication:
United States
Language:
English